FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183233967> ?p ?o ?g. }

• W3183233967 abstract "Background: This study aimed to evaluate the clinical efficacy of Yun-type optimized pelvic floor training therapy for middle-aged women with severe overactive bladder (OAB). Methods: This randomized, observer-blinded, parallel-group controlled clinical trial included 108 middle-age women with severe OAB and assigned them to the intervention group (treated with combination of Yun-type optimized pelvic floor training with solifenacin for 12 weeks) and control group (treated with solifenacin for 6 weeks and, after 2 weeks of elution, received the combination of Yun-type optimized pelvic floor training and solifenacin for 6 weeks). The outcomes associated with OAB, pelvic floor muscle (PFM) function, and sexual function were compared after 6 and 12/14 weeks of treatment. Results: The primary variables were OAB-associated outcomes, including overactive bladder symptom score (OABSS), urgent urination, urine, nocturia, urge urinary incontinence, patient's perception of bladder condition, urogenital distress inventory-6, incontinence impact questionnaire-7, voiding volume, average flow rate, and maximum flow rate. The secondary variables were indicators related to PFM function and sexual function. These indicators were significantly improved in both groups after interventions. Notably, the improvements in most of these indicators were superior in the intervention group than in the control group after 6 weeks and 12/14 weeks of treatment. Conclusions: The use of Yun-type optimized pelvic floor training adds to the benefits of solifenacin regarding severe OAB-associated outcomes, PMF function, and sexual function in middle-aged women with severe OAB. Combining Yun-type optimized pelvic floor training with traditional drug therapies may improve clinical outcomes in patients with severe OAB. Trial Registration: ChiCTR-INR-17012189." @default.
• W3183233967 created "2021-08-02" @default.
• W3183233967 creator A5018137593 @default.
• W3183233967 creator A5047329088 @default.
• W3183233967 creator A5061122617 @default.
• W3183233967 creator A5063651972 @default.
• W3183233967 creator A5078076080 @default.
• W3183233967 creator A5088821878 @default.
• W3183233967 date "2021-07-14" @default.
• W3183233967 modified "2023-09-27" @default.
• W3183233967 title "Efficacy of Yun-Type Optimized Pelvic Floor Training Therapy for Middle-Aged Women With Severe Overactive Bladder: A Randomized Clinical Trial" @default.
• W3183233967 cites W1895721865 @default.
• W3183233967 cites W1968922576 @default.
• W3183233967 cites W1969093324 @default.
• W3183233967 cites W1986758727 @default.
• W3183233967 cites W1991097426 @default.
• W3183233967 cites W1999208952 @default.
• W3183233967 cites W2012212485 @default.
• W3183233967 cites W2023825779 @default.
• W3183233967 cites W2043742417 @default.
• W3183233967 cites W2048966719 @default.
• W3183233967 cites W2068451975 @default.
• W3183233967 cites W2084355008 @default.
• W3183233967 cites W2089543827 @default.
• W3183233967 cites W2108691316 @default.
• W3183233967 cites W2131173377 @default.
• W3183233967 cites W2151290477 @default.
• W3183233967 cites W2170438898 @default.
• W3183233967 cites W2170939348 @default.
• W3183233967 cites W2548532314 @default.
• W3183233967 cites W2597612941 @default.
• W3183233967 cites W2770867475 @default.
• W3183233967 cites W2794391538 @default.
• W3183233967 cites W2796922519 @default.
• W3183233967 cites W2800513943 @default.
• W3183233967 cites W2804975780 @default.
• W3183233967 cites W2883479536 @default.
• W3183233967 cites W2912917820 @default.
• W3183233967 cites W2945773301 @default.
• W3183233967 cites W2949822323 @default.
• W3183233967 cites W2969568523 @default.
• W3183233967 cites W2977595607 @default.
• W3183233967 cites W3000657215 @default.
• W3183233967 cites W3004361264 @default.
• W3183233967 cites W3019548901 @default.
• W3183233967 cites W3088775247 @default.
• W3183233967 cites W4246058131 @default.
• W3183233967 doi "https://doi.org/10.3389/fsurg.2021.670123" @default.
• W3183233967 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8316598" @default.
• W3183233967 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34336915" @default.
• W3183233967 hasPublicationYear "2021" @default.
• W3183233967 type Work @default.
• W3183233967 sameAs 3183233967 @default.
• W3183233967 citedByCount "2" @default.
• W3183233967 countsByYear W31832339672022 @default.
• W3183233967 countsByYear W31832339672023 @default.
• W3183233967 crossrefType "journal-article" @default.
• W3183233967 hasAuthorship W3183233967A5018137593 @default.
• W3183233967 hasAuthorship W3183233967A5047329088 @default.
• W3183233967 hasAuthorship W3183233967A5061122617 @default.
• W3183233967 hasAuthorship W3183233967A5063651972 @default.
• W3183233967 hasAuthorship W3183233967A5078076080 @default.
• W3183233967 hasAuthorship W3183233967A5088821878 @default.
• W3183233967 hasBestOaLocation W31832339671 @default.
• W3183233967 hasConcept C121608353 @default.
• W3183233967 hasConcept C126322002 @default.
• W3183233967 hasConcept C126894567 @default.
• W3183233967 hasConcept C141071460 @default.
• W3183233967 hasConcept C142724271 @default.
• W3183233967 hasConcept C168563851 @default.
• W3183233967 hasConcept C175768497 @default.
• W3183233967 hasConcept C1862650 @default.
• W3183233967 hasConcept C204787440 @default.
• W3183233967 hasConcept C2775871022 @default.
• W3183233967 hasConcept C2776235491 @default.
• W3183233967 hasConcept C2776547966 @default.
• W3183233967 hasConcept C2777333188 @default.
• W3183233967 hasConcept C2778531004 @default.
• W3183233967 hasConcept C2778941218 @default.
• W3183233967 hasConcept C2779478474 @default.
• W3183233967 hasConcept C2779502394 @default.
• W3183233967 hasConcept C2781244320 @default.
• W3183233967 hasConcept C2908639710 @default.
• W3183233967 hasConcept C71924100 @default.
• W3183233967 hasConcept C77411442 @default.
• W3183233967 hasConceptScore W3183233967C121608353 @default.
• W3183233967 hasConceptScore W3183233967C126322002 @default.
• W3183233967 hasConceptScore W3183233967C126894567 @default.
• W3183233967 hasConceptScore W3183233967C141071460 @default.
• W3183233967 hasConceptScore W3183233967C142724271 @default.
• W3183233967 hasConceptScore W3183233967C168563851 @default.
• W3183233967 hasConceptScore W3183233967C175768497 @default.
• W3183233967 hasConceptScore W3183233967C1862650 @default.
• W3183233967 hasConceptScore W3183233967C204787440 @default.
• W3183233967 hasConceptScore W3183233967C2775871022 @default.
• W3183233967 hasConceptScore W3183233967C2776235491 @default.
• W3183233967 hasConceptScore W3183233967C2776547966 @default.
• W3183233967 hasConceptScore W3183233967C2777333188 @default.
• W3183233967 hasConceptScore W3183233967C2778531004 @default.
• W3183233967 hasConceptScore W3183233967C2778941218 @default.

• next